Edrecolomab (Panorex) as adjuvant therapy for stage II colon cancer.
Gambill
B D
BD
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D017024:Chemotherapy, Adjuvant; D017326:Clinical Trials, Phase III as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; C400149:Edrecolomab